COMMUNIQUÉS West-GlobeNewswire
-
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
09/09/2026 -
Zelluna ASA – Extraordinary General Meeting held on September 9, 2026
09/09/2026 -
Medicana Uses Robot-Assisted Technology to Perform Heart Surgery Through Small Ports
09/09/2026 -
BayCare Generates $13 Billion in Economic Impact Annually for Florida
09/09/2026 -
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
09/09/2026 -
Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors
09/09/2026 -
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
09/09/2026 -
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
09/09/2026 -
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
09/09/2026 -
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026 -
Invisible Balance Disorders Affect Millions
09/09/2026 -
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
09/09/2026 -
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
09/09/2026 -
ABBYY Study Finds Business Leaders Disagree on Who Has Ultimate Responsibility When AI Goes Wrong
09/09/2026 -
Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus
09/09/2026 -
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
09/09/2026 -
LifeStance Health Group Announces Launch of Secondary Public Offering
09/09/2026 -
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation
09/09/2026 -
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
09/09/2026
Pages